My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 428

    1.

    Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

    Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

    Diabetes. 2001 Feb;50(2):270-6.PMID: 11272136 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.

    Berney T, Pileggi A, Molano RD, Poggioli R, Zahr E, Ricordi C, Inverardi L.

    Transplantation. 2003 Dec 27;76(12):1669-74.PMID: 14688513 [PubMed - indexed for MEDLINE]Related articles

    3.

    Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.

    Demirci G, Strom TB, Li XC.

    J Immunol. 2003 Oct 1;171(7):3878-85.PMID: 14500690 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.

    Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.

    Transplantation. 2001 Jun 15;71(11):1656-65.PMID: 11435979 [PubMed - indexed for MEDLINE]Related articles

    6.

    Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

    Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL.

    Diabetes. 2009 Jan;58(1):165-73. Epub 2008 Nov 4.PMID: 18984741 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.

    Appel MC, Banuelos SJ, Greiner DL, Shultz LD, Mordes JP, Rossini AA.

    Transplantation. 2004 May 15;77(9):1341-9.PMID: 15167588 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.

    Arefanian H, Tredget EB, Rajotte RV, Korbutt GS, Gill RG, Rayat GR.

    Cell Transplant. 2007;16(8):787-98.PMID: 18087999 [PubMed - indexed for MEDLINE]Related articles

    9.

    Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.

    Diabetes. 2006 Jan;55(1):27-33.PMID: 16380473 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.

    Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL.

    Blood. 2000 Mar 15;95(6):2175-82.PMID: 10706892 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    NOD mice have a generalized defect in their response to transplantation tolerance induction.

    Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA.

    Diabetes. 1999 May;48(5):967-74.PMID: 10331399 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Anti-CD154 mAb treatment but not recipient CD154 deficiency leads to long-term survival of xenogeneic islet grafts.

    Mai G, Bucher P, Morel P, Mei J, Bosco D, Andres A, Mathe Z, Wekerle T, Berney T, Bühler LH.

    Am J Transplant. 2005 May;5(5):1021-31.PMID: 15816882 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody.

    Jung da Y, Kim EY, Joo SY, Park JB, Moon C, Kim SH, Sim EY, Joh JW, Kwon CH, Kwon GY, Kim SJ.

    Exp Mol Med. 2008 Feb 29;40(1):1-10.PMID: 18305392 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

    Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

    Transplantation. 2002 Sep 15;74(5):611-9.PMID: 12352875 [PubMed - indexed for MEDLINE]Related articles

    15.

    Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD154 on murine islet transplantation recipients.

    Jung DY, Lee HJ, Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Lee SK, Joh JW, Kwon GY, Kim SJ.

    Transplantation. 2006 Jul 27;82(2):188-95.PMID: 16858281 [PubMed - indexed for MEDLINE]Related articles

    16.

    Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.

    Banuelos SJ, Markees TG, Phillips NE, Appel MC, Cuthbert A, Leif J, Mordes JP, Shultz LD, Rossini AA, Greiner DL.

    Transplantation. 2004 Sep 15;78(5):660-7.PMID: 15371665 [PubMed - indexed for MEDLINE]Related articles

    17.

    Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.

    Stegall MD, Loberman Z, Ostrowska A, Coulombe M, Gill RG.

    J Surg Res. 1996 Aug;64(2):156-60.PMID: 8812627 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.

    Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Malek TR, Ricordi C, Inverardi L.

    Transplantation. 2003 Jun 15;75(11):1812-9.PMID: 12811239 [PubMed - indexed for MEDLINE]Related articles

    19.

    Transplantation of discordant xenogeneic islets using repeated therapy with anti-CD154.

    Bucher P, Gang M, Morel P, Mathe Z, Bosco D, Pernin N, Wekerle T, Berney T, Buhler LH.

    Transplantation. 2005 Jun 15;79(11):1545-52.PMID: 15940044 [PubMed - indexed for MEDLINE]Related articles

    20.

    BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.

    Lakey JR, Singh B, Warnock GL, Rajotte RV.

    Transplantation. 1994 Apr 27;57(8):1213-7.PMID: 8178349 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity